Researchers in Germany have found a new way to exploit the differences between cancer cells and normal cells that could lead to new treatments.
Jun 13, 2013
5 / 5 (2) | 0 |
Two clinical studies published in the New England Journal of Medicine with an accompanying editorial suggest that the novel agent ibrutinib shows real potential as a safe, effective, targeted treatment for ad ...
9 hours ago
5 / 5 (1) | 0 |